Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, announced the successful acquisition of PKG Health, a leading innovator in movement disorder algorithms and digital endpoints for Parkinson’s disease. The deal enhances Empatica’s robust, FDA-cleared wearable technology and health monitoring platform with PKG Health’s validated algorithms for movement disorder monitoring, significantly broadening Empatica’s reach and market potential within neurology research, clinical care, and diagnostics.
Read the full article: Empatica Acquires PKG Health to Transform Parkinson’s Disease Monitoring //
Source: https://www.businesswire.com/news/home/20250924681791/en/Empatica-Acquires-PKG-Health-to-Transform-Parkinsons-Disease-Monitoring